“Artificial Intelligence Regulation is Out!”
"Countries are planning to introduce laws to strictly control AI."
"Technology giants held an urgent meeting to discuss the development of standards for how to use artificial intelligence technology."
"Sanqing officially announced that they will join forces to build a large-scale model platform and start an epic transformation in the medical field."
"Breaking news! These tertiary hospitals will be connected to artificial intelligence services, and the era of AI medical treatment is coming."
"Dami is involved in the AI war, large-scale domestic models are released together, and the AI track is popular all over the world."
"Mabuse entered the big model, purchased 10,000 GPUs, and shorted the graphics card market."
"After discovering that his works were used to train artificial intelligence, Eagle Country artists filed a class action lawsuit against the relevant AI companies."
"After the original painting team of a game company introduced AI software, they laid off 2/3 of their employees, saving 200,000 yuan in monthly costs and increasing efficiency by 50%."
"A Putian shoe factory laid off its marketing team and used AI to create tens of thousands of advertisements for distribution through channels."
“A leading fund company announced that it will fully explore the application of artificial intelligence, and AI stock trading may become a reality.
"The singularity is coming, and AI may start a new round of technological revolution."
News related to artificial intelligence are constantly breaking out, and netizens are stunned.
"Nima AI is out for stock trading? Isn't this the same as cheating in games? From now on, retail investors will completely become leeks."
"It's hard to say. Since they are all game cheats, there must be some who sell them. You can just buy them with money."
"Brother Fu upstairs v. I'm 50, I'm cheating."
"These companies are crazy, and they want to have anything to do with AI, even if they can't even deal with it."
"Domestic AI is still not good. Except for Sanqing, no one can do to c. The actual level is not transparent at all, and it is incomparable with chatgpt."
“Actually, it’s okay to be able to do TO B’s AI painting function like midjournry, but the AI led by these leading manufacturers are all so-called empowering the original business, spinning around in their own circles, with no technical content at all, and the investment is not the same. It cannot be compared with foreign countries.”
"Why do I feel that bosses in traditional industries are embracing AI faster? In the future, except for large companies, other companies can fire their advertising and marketing teams."
"In addition to artists, designers are also unemployed. Our company forces the design team to learn AI, and those who can't learn it will be fired. In the past, at least five designers needed to complete the work, but now only one designer can complete it using AI. .”
"Programmers are slightly better, because most people can't understand code. Even if AI is used, coders are still needed to operate and communicate. Moreover, we have information security considerations. Currently, it is only used to consult some questions, and the data cannot be transferred yet. Upload it to AI to avoid leaking the secret."
"Another point is that there are no copyright issues for drawings and articles for the time being, but our code needs to be checked for plagiarism. If you directly copy the code generated by chatgpt, there will be copyright risks."
"Our clothing brand is already using AI models in e-commerce channels. They are much easier to use than real models. We don't need to take photos for several days. We only need to create them with one click, saving tens of thousands of yuan in shooting costs. , this AI is really a good thing.”
"Dear sister, now in the weekly department meeting, after the work report, everyone has to take turns to analyze their own experience in using AI tools. To be honest, under the flood of technology, all workers are just ants, and they can only join in actively or passively. There is no room for resistance at all.”
"Hey, I am very anxious every day. Every time I use AI to draw, if the drawing drawn by AI is terrible, I will be very happy. I will be happy all day long. Then if I see other people using AI to draw very exquisite I will fall into anxiety again, forming an endless loop, and I am really hopeless."
"The market is getting more and more complicated, and workers are becoming more and more stupid. Everyone says they are not interested in AI, but privately everyone is crazy about learning AI."
"That's right, these stupid colleagues, every time the company holds an AI lecture, none of them say they can go. I look back and see if the tickets are gone."
"The only ones who are still resisting AI are probably the original painters. I think their resistance to AI painting has never weakened. What about 'stitch monsters' and 'corpse splicing'? I guess they will make a big splash sooner or later." of."
"They, haha, I'm not saying that, the wave of AI is rolling in, and everyone can't resist it. They are just trying to control the situation."
"We are all workers. We are just struggling between our resistance to AI and the company's rigid requirements. We are making money, not shabby."
"I'm a little excited to think about witnessing the beginning of a new AI era."
"I have talked about the six major principles of supervision, but the most critical ones have not been mentioned. For example, is AI painting an infringement?"
"You know, this is probably going to have to cause trouble before detailed regulations can be issued. You see, artists and companies in Eagle Country are suing on their own. When we come here too, the rules will probably be finalized."
"Right now, we are all trying to cross the river by feeling the stones. We can only issue guidelines. No one can say the specifics. We have to discuss things on a case-by-case basis."
"Actually, I am more interested in Sanqing's AI-connected hospitals. There are not many pilot hospitals on the list, no more than ten, and they are all non-top tertiary hospitals in first- and second-tier cities."
"That's great, but I didn't write down a specific implementation date. I gave a relatively rough time, saying it would be after the Spring Festival."
"It also takes time to implement it. Coordination from top to bottom, standardization of processes, and access to big data. It can be done within a month or two, which is already very impressive."
"Xiaomei can treat us now, but it can only be used as a reference. It is for informal use. When it is officially connected to the hospital, it will be able to actually treat doctors and prescribe medicine. Let's wait and see."
Netizens have different opinions and say whatever they want, but everyone is clearly aware of it.
AI has completely evolved from an arms race among large factories to a workplace revolution that affects the life and death of every ordinary worker.
Destroying your job has nothing to do with you.
Only by embracing AI can we have a future.
They must keep up with this trend in order to have a place in the new era of workplace.
Driven by Sanqing, AI technology will also penetrate into the medical field and truly enter people's lives in a subtle way.
****
Kunming City, Sanqing Headquarters.
Wei Kang sat in a large office chair and browsed the latest news.
As a company CEO, his focus is naturally more professional than ordinary people.
"Hundreds of billions of funds have been poured into the AI medical field, and listed companies are rushing to deploy. Haha, they are following quite quickly."
"Every listed pharmaceutical company is frantically seizing on this trend and taking advantage of the upcoming upgrade of the pharmaceutical industry to realize commercialization."
"AI medical imaging has become the forefront of AI medical commercialization. There are many companies deploying in-hospital informatization, as well as automated pharmacy companies. In addition, AI-assisted drug design is also very popular among pharmaceutical companies."
"In fact, AI medical treatment has always been very popular. The domestic enthusiasm for this aspect has been in countless waves. Unfortunately, it is in a situation where it is not popular. Until now, Sanqing's diagnostic AI turned out to be considered for They point a direction.”
"Compared with intelligent driving and general AI, AI medical care faces very serious ethical issues, which limits its height and development. It must be supervised by doctors before it can be truly implemented."
“Medical data is also a major pain point. High-quality, diverse and well-annotated data is the main technical bottleneck. These companies do not have their own data pools and must cooperate with hospitals to obtain data. This involves a privacy protection issue. . If Sanqing didn’t have the private domain data pool of Longtu, it would probably be difficult to move forward.”
"As for algorithm barriers, these companies use general open source AI, and then make some improvements according to their own business. They have no unique skills. They are completely different from Sanqing, and the threat is not great."
"AI is currently unable to replace doctors and can only play an auxiliary role. After all, one of the difficulties in AI-integrated medical care is supervision and accountability. We can only move forward step by step."
"Start with the function of auxiliary doctors, and use strong analytical and decision-making capabilities to participate in all aspects of pre-hospital, in-hospital, and post-hospital processes to promote the rational allocation of medical resources and truly serve doctors and patients."
"This is the best path AI can take at the moment."
After reading the industry news, he turned his attention to the freshly released financial reports.
The financial reports came out later and later every year, and they were not delivered to his desk until just before the Chinese New Year.
But since the numbers on the financial report were so pretty, he didn't mind too much.
This is already the seventh year, and it still maintains rapid growth, exceeding the 100 billion U.S. dollar mark, reaching 100.1 billion.
In addition to inherent revenue, compared with the previous year, performance growth mainly lies in two major areas.
One is the launch of artificial blood, which has alleviated the global blood crisis and is widely sought after. The other is the domestic business of ultrasonic scalpels and endoscopes. With the support of policies, it has occupied the majority of the domestic market.
Coupled with the overseas listing of Xiaofening and the large-scale purchases by all parties, this brilliant performance was achieved.
"What a risk. 100.1 billion is an extra 100 million. If it's just a little bit short, we won't be able to surpass it." Thinking of this, Wei Kang couldn't help but call it a fluke.
"Oral insulin was still in the clinical stage last year and will not be launched until this year. Otherwise, if the performance of this flagship drug is added, it is estimated that another 10 billion will be added."
"The difference between 100 billion and more than 90 billion is not big, but they sound completely different."
"Now, compared to Johnson & Johnson and Pfizer, it's a little higher."
Wei Kang looked at the financial reports of his friends and couldn't help but smile with relief.
"Last year, Johnson & Johnson's revenue was 97.8 billion U.S. dollars. In comparison, Sanqing's revenue was more than 2 billion U.S. dollars. The difference is not big. It is a narrow victory. If it were a little worse, it is probably overtaken by the other party."
"As for Pfizer, we have also surpassed it in the pharmaceutical field. They lack the device business, and they may not be able to catch up even if they try to catch up in the future."
"Sanqing not only surpassed Pfizer in medicine, but also completely surpassed Johnson & Johnson in terms of total revenue, finally reaching the top spot in the world."
"Not only that, no pharmaceutical company has ever achieved a revenue of over 100 billion before. The third liquidation hit a record high and broke the record of the medical industry."
"The world's No. 1 pharmaceutical company and the first pharmaceutical company with revenue exceeding 100 billion, Sanqing has single-handedly raised the revenue ceiling of the industry."
"Seven years. It took me seven years to finally become the first in the industry. It's easy for me."
Thinking of the hardships and growth along the way, Wei Kang couldn't help but burst into tears with mixed feelings in his heart.
"This world is too cruel. Even if there are failures, we still need to keep working hard. After all, products and performance will not fall from the sky."
"The hardships involved cannot be explained to outsiders."
“It’s all thanks to my hard work that I am what I am today.”
"No. 1 in the world, No. 1 in the world."
"I have waited too long for today."
The more Wei Kang thought about it, the more excited he became. He couldn't help but get up and walk around. He paced back and forth for a long time before slowly regaining his composure.
"We must publicize it well and share this joy with the people across the country. We can no longer be as low-key as usual."
"This is big news that brings glory to the country. The media and officials will definitely like it very much."
"You can keep a low profile if you rank first in the exam, but there is no need to be humble anymore if you rank first in the exam, otherwise it will be hypocrisy."
"The glory of China's medical industry will be guarded by Sanqing and continue to be carried forward, hahaha."
Thinking of this, Wei Kang couldn't help laughing, and a burst of hearty laughter echoed in the office.
He lay back casually and leaned on the soft and thick back of the chair. His whole body relaxed, and his expression was leisurely but also full of enthusiasm.
"From now on, Sanqing's goal is to remain number one and continue to break through the upper limit of the medical industry."
"The Hundred Billion Dollar Club, I'm here, and I will go further in the future."
If a company can reach revenue of 100 billion US dollars, it is a great thing.
Hundreds of billion dollar companies, in any industry in the world, are super giants that can influence the entire industry. Every name is famous and thunderous.
In this world, there are only 9 countries with companies worth hundreds of billions of dollars, all in the West and East Asia.
Above the 100 billion U.S. dollars, there are the 200 billion U.S. dollars and 300 billion U.S. dollars. Currently, the only technology company at the 300 billion U.S. dollars level is Fruit, and the others are resource companies such as supermarket chains and power grids.
The 200 billion level are also large monopoly giants and resource companies, and Bangguo's Two Star is considered relatively famous in this level.
It is easy for resource and monopoly enterprises to produce super giants, but this can only explain the scale but not the technical content.
The true strength of a country depends on how many technology and manufacturing companies there are in the 100-billion-dollar club.
To achieve the prosperity of the country and the rejuvenation of the nation, we must gain advantages in the field of science and technology and emerge more billionaire giants.
There are only 16 companies with hundreds of billions of dollars in the whole of China. Except for a few Internet giants, the only high-tech company is Juwei. The others are state-owned enterprises in banking, petroleum, construction, insurance, telecommunications and other industries.
Now, the medical industry finally has a billionaire giant.
And the most rare thing is that it is a high-tech pharmaceutical and device company, rather than a pharmaceutical sales and insurance company.
Because there are also hundreds of billions of medical-related companies in Eagle Country, but they are all retailers and distributors in pharmaceutical sales, prescription management, and medical insurance. They are monopoly resources, not high-tech enterprises, and they still involve the entire Eagle Country. The healthcare system is extremely expensive to light.
It took Sanqing seven years of hard work to get into this 100-billion-dollar club.
Further up, Wei Kang can only look up to the US$200 billion and US$300 billion clubs, but cannot yet touch them.
The ceiling of an industry is limited, and medicine is not a monopoly mass consumer category. Unless it can stay on the forefront and constantly explore new fields, it will be difficult to move forward.
Fortunately, Sanqing has always been at the forefront, constantly investing heavily in scientific research, developing new projects, and seizing the technology track.
Each new project can continue to bring massive revenue, continuously adding bricks and tiles and taking solid steps to enter the US$200 billion or even US$300 billion club.
This time AI medical treatment is a very good new direction.
In the future, there will be new tracks that can break through industry barriers and make the entire market bigger, as well as new directions such as artificial organs and brain-computer interfaces.
In this regard, Wei Kang is ambitious and confident.
If a super giant with a revenue of US$300 billion really emerges in the global medical industry, who else could it be besides Sanqing?
